Citation Impact
Citing Papers
Physical Activity and Public Health
2007 Standout
Sex Differences in the Gut Microbiome Drive Hormone-Dependent Regulation of Autoimmunity
2013 StandoutScience
Frailty in Older Adults: Evidence for a Phenotype
2001 Standout
Thiazolidinediones
2004 Standout
Hyperglycaemia and mortality from all causes and from cardiovascular disease in five populations of Asian origin
2004
Long-Term Trends in the Incidence of and Survival with Heart Failure
2002 Standout
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study
2000
Mechanisms of Thrombus Formation
2008 Standout
Multiple Biomarkers for the Prediction of First Major Cardiovascular Events and Death
2006 Standout
Clinical Significance, Pathogenesis, and Management of Postprandial Hyperglycemia
2003
Discovery of Sexual Dimorphisms in Metabolic and Genetic Biomarkers
2011
An Increase in the Number of Deaths in the United States in the First Week of the Month — An Association with Substance Abuse and Other Causes of Death
1999
National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants
2011 Standout
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
2003 Standout
C-Reactive Protein Levels and Outcomes after Statin Therapy
2005 Standout
Relationship between blood glucose level and mortality in Type 2 diabetes mellitus: a systematic review
1999
Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders
2009 Standout
Alcohol and public health
2005 Standout
Exposure to Traffic and the Onset of Myocardial Infarction
2004
Physical Exertion as a Trigger of Acute Myocardial Infarction
1993
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
2000 Standout
Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study
2007 Standout
Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction
1998 Standout
Comparison of C-Reactive Protein and Low-Density Lipoprotein Cholesterol Levels in the Prediction of First Cardiovascular Events
2002 Standout
Rapid Response to Stroke Symptoms: The Delay in Accessing Stroke Healthcare (DASH) Study
1998
von Willebrand factor and coronary heart disease. Prospective study and meta-analysis
2002
Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels
1993
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Platelet Activation and Atherothrombosis
2007 Standout
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
2017 Standout
Plasma lipoproteins, apoproteins and cardiovascular disease in Type 2 diabetic patients. A nine-year follow-up study
2003
Type 2 diabetes
2017 Standout
Therapeutic implications of the gender-specific aspects of cardiovascular disease
2006
C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease
2004 Standout
The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus
2001
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
Estrogen plus Progestin and the Risk of Coronary Heart Disease
2003 Standout
Chronobiology of acute myocardial infarction: Cardiac arrhythmia suppression trial (CAST) experience
1996
Carotid-Artery Intima and Media Thickness as a Risk Factor for Myocardial Infarction and Stroke in Older Adults
1999 Standout
Hyperglycemia and hyperinsulinemia at diagnosis of diabetes and their association with subsequent cardiovascular disease in the United Kingdom Prospective Diabetes Study (UKPDS 47)
1999
Actual Causes of Death in the United States, 2000
2004 Standout
Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes
2008 Standout
Glycemic control and cardiovascular disease in Type 2 diabetes: a review
1999
Inflammation, Atherosclerosis, and Coronary Artery Disease
2005 Standout
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
2008 Standout
Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials
2009
C-Reactive Protein and Other Markers of Inflammation in the Prediction of Cardiovascular Disease in Women
2000 Standout
Saxagliptin and Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus
2013 Standout
Surveillance and ascertainment of cardiovascular events
1995
Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
1996 Standout
Obesity and the Metabolic Syndrome in Children and Adolescents
2004 Standout
The Tumor Necrosis Factor Ligand and Receptor Families
1996 StandoutNobel
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
1994 Standout
2003
Markers of Inflammation and Cardiovascular Disease
2003 Standout
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
2003 Standout
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
[Alcohol-related morbidity and mortality].
2021
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
2009 Standout
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Average Volume of Alcohol Consumption, Patterns of Drinking and Risk of Coronary Heart Disease - A Review
2003
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects
1999
Lipoprotein-Associated Phospholipase A 2 Adds to Risk Prediction of Incident Coronary Events by C-Reactive Protein in Apparently Healthy Middle-Aged Men From the General Population
2004
Intensive Integrated Therapy of Type 2 Diabetes
2004
Inflammation and Atherosclerosis
2002 Standout
Effect of a Multifactorial Intervention on Mortality in Type 2 Diabetes
2008 Standout
Is Workers' Compensation Covering Uninsured Medical Costs? Evidence from the “Monday Effect”
1996 StandoutNobel
Ambient Air Pollution Is Associated With Increased Risk of Hospital Cardiac Readmissions of Myocardial Infarction Survivors in Five European Cities
2005
Coronary Plaque Disruption
1995 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled Trial
2002 Standout
Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
2010 Standout
Reducing the global burden of hazardous alcohol use: a comparative cost-effectiveness analysis.
2004
C-Reactive Protein, Interleukin 6, and Risk of Developing Type 2 Diabetes Mellitus
2001 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
C-Reactive Protein Modulates Risk Prediction Based on the Framingham Score
2004
C-Reactive Protein, a Sensitive Marker of Inflammation, Predicts Future Risk of Coronary Heart Disease in Initially Healthy Middle-Aged Men
1999 Standout
Works of A. Hörmann being referenced
Case finding, data quality aspects and comparability of myocardial infarction registers: Results of a south German register study
1991
Prognostische Bedeutung der Prähospitalphase beim akuten Myokardinfarkt: Ergebnisse des Augsburger Herzinfarktregisters 1985-1988
2008
Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Practitioner Project
1996
The Population-Based Acute Myocardial Infarction (AMI) Registry of the MONICA/KORA Study Region of Augsburg
2005
Geschlechtsspezifische Trends von plötzlichem Herztod und akutem Herzinfarkt
2002
Weekly variation of acute myocardial infarction. Increased Monday risk in the working population.
1994